Change - Announcement of Appointment::Announcement of Appointment of Executive Director and Chief Commercial Officer

Issuer & Securities

Issuer/ Manager
LIVINGSTONE HEALTH HOLDINGS LIMITED
Securities
LIVINGSTONE HEALTH HLDGS LTD - SGXE70643320 - PRH
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Appointment
Date &Time of Broadcast
08-Jul-2024 06:50:52
Status
New
Announcement Sub Title
Announcement of Appointment of Executive Director and Chief Commercial Officer
Announcement Reference
SG240708OTHR78AC
Submitted By (Co./ Ind. Name)
Tay Ching Yit, Wilson
Designation
Executive Director and Chief Executive Officer
Description (Please provide a detailed description of the event in the box below)
This announcement has been reviewed by the Company's sponsor, SAC Capital Private Limited (the "Sponsor"). This announcement has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "SGX-ST") and the SGX-ST assumes no responsibility for the contents of this announcement, including the correctness of any of the statements or opinions made or reports contained in this announcement. The contact person for the Sponsor is Ms Lee Khai Yinn at 1 Robinson Road, #21-00 AIA Tower, Singapore 048542, Telephone (65) 6232 3210.

Additional Details

Date Of Appointment
08/07/2024
Name Of Person
Dax Ng Yung Sern
Age
45
Country Of Principal Residence
Singapore
The Board's comments on this appointment (including rationale, selection criteria, board diversity considerations, and the search and nomination process)
The Board of Directors, having considered the recommendation of the Nominating Committee and having reviewed and considered the qualifications, working experience, and suitability of Mr. Dax Ng Yung Sern ("Mr. Dax Ng"), is of the view that Mr. Dax Ng has the requisite experience and capability to assume the responsibility as an Executive Director and Chief Commercial Officer of the Company.

Accordingly, the Board of Directors approved the appointment of Mr. Dax Ng as an Executive Director and Chief Commercial Officer of the Company.
Whether appointment is executive, and if so, the area of responsibility
Executive
Chief Commercial Officer

- Commercial and corporate development of the Company and its subsidiaries and business interest.
- Marketing and business development including strategic partnerships and business operational partnerships.
- Works with the CEO and CFO on financial and corporate development matters including corporate finance, fundraising, and deployment.
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Executive Director and Chief Commercial Officer
Professional qualifications
1. Associate member of Singapore Institute of Directors
2. National University of Singapore (NUS) School of Medicine: Artificial Intelligence (AI) for healthcare
3. Singapore Management University (SMU) Academy:
a. Conceptualizing Smart healthcare solutions
b. Analytics for Healthcare
c. Legal issues and risk management in Healthcare
d. Managing partnerships in digital health - Insurers & Insurance
e. Digital healthcare leadership
4. Certificate in Prescription Drug Regulation, Cost, and Access: Current Controversies in Context at HarvardX
5. Certificate of Completion for MIT Fintech: Future Commerce online course at Massachusetts Institute of Technology
6. SMU Financial Training Institute Certificate: Framework for Conducting Private Equity Due Diligence (V) at Singapore Management University Financial Training Institute
7. SMU Financial Training Institute Certificate: Implementing Private Equity Exit Strategies (V) at Singapore Management University Financial Training Institute
8. SMU Financial Training Institute Certificate: Sourcing Private Equity Deals & Fund Raising (V) at Singapore Management University Financial Training Institute
9. Capital Markets and Financial Advisory Services Examinations Module 6A - Securities and Futures Product Knowledge at The Institute of Banking & Finance
10. Capital Markets and Financial Advisory Services Examinations Module 9A - Life Insurance and Investment-Linked Policies II at Singapore College of Insurance
11. Capital Markets and Financial Advisory Services Examinations Module 8A - Collective Investment Schemes II at Singapore College of Insurance
12. Capital Markets and Financial Advisory Services Examinations Module 1B - Rules and Regulations for Dealing in Securities (Non-SGX-ST Members) at The Institute of Banking & Finance
13. Capital Markets and Financial Advisory Services Examinations Module 8 - Collective Investment Schemes at Singapore College of Insurance
14. Capital Markets and Financial Advisory Services Examinations Module 9 - Life Insurance and Investment-Linked Policies at Singapore College of Insurance
15. Certificate in Health Insurance Examination at Singapore at College of Insurance
16. Bachelor of Engineering (Chemical Engineering) at University of New South Wales
17. Capital Markets and Financial Advisory Services Examinations Module 5 - Rules and Regulations for Financial Advisory Services at Singapore College of Insurance
Any relationship (including immediate family relationships) with any existing director, existing executive officer, the issuer and/ or substantial shareholder of the listed issuer or any of its principal subsidiaries
Yes. Mr. Dax Ng holds 12.88% interest in Livingstone Health Consolidated Pte Ltd, being the controlling shareholder of the Company.

Mr. Dax Ng is also the brother of Dr Ng Yung Chuan, Sean ("Dr Sean") and brother in law of Dr Lim Pang Yen Rachel ("Dr Rachel Lim"). Dr Sean Ng is a practising doctor of the Group and Dr Rachel Lim is the Chief Operating Officer and Head of Aesthetics and Wellness of the Group. Dr Rachel Lim holds 17.35% interest in Livingstone Health Consolidated Pte Ltd.
Conflict of interests (including any competing business)
No
Working experience and occupation(s) during the past 10 years
1. January 2020 - Current: Chief Business Officer at Livingstone Health Holdings Limited
2. December 2018 - December 2019: Chief Investment Officer at Livingstone Health Ltd.
3. January 2018 - March 2019: Executive Director at Naki Consolidated Pte Ltd
4. November 2014 - December 2017: Managing Director at TEHO Development (Cambodia) Pte. Ltd.
5. February 2005 - November 2014: Senior Vice President (Network Director) at The Hongkong and Shanghai Banking Corporation Limited
Undertaking submitted to the listed issuer in the form of Appendix 7.7 (Listing Rule 704(7)) Or Appendix 7H (Catalist Rule 704(6))
Yes
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Mr. Dax Ng has a direct interest in 10,489,576 ordinary shares of the Company representing 1.79% of the total issued share capital of the Company, and a 12.88% interest in Livingstone Health Consolidated Pte. Ltd., a controlling shareholder holding 258,373,267 shares in the Company.

Mr. Dax Ng also holds 1,748,262 Warrants pursuant to the Rights cum Warrants Issue of the Company announced on 27 March 2024.
# These fields are not applicable for announcements of appointments pursuant to Listing Rule 704 (9) or Catalist Rule 704 (8).
Past (for the last 5 years)
Directorships
- AC Venture Pte. Ltd.
- Al Tirah Anaesthesia Services Pte Ltd
- Cove Sports & Reconstruction Pte Ltd
- Livingstone Endocrine Pte Ltd
- Precision Medical Services Pte Ltd
- The Bone and Joint Centre Pte Ltd
- Livingstone Gastroenterology & Liver Pte Ltd
- Quantum Orthopaedics Pte Ltd
- Atlas Physiotherapy Pte Ltd (f.k.a Activfix Pte Ltd)
- Venture Investments Pte Ltd
- Atlas Podiatry Pte Ltd
- PMGXX PTE. LTD.
- Livingstone Soriya Medical Specialists Co., Ltd (dissolved on 8 March 2023)

Principal Commitments
- Chief Investment Officer at Livingstone Health Ltd.
Present
Directorships
- Livingstone Health Consolidated Pte. Ltd.
- Livingstone Health International Pte. Ltd.
- Phoenix Medical Group Pte. Ltd.
- PMG TH Pte Ltd
- PMGPO Pte Ltd
- PMG INT2 Pte Ltd
- Prism Partnerships (SG) Pte Ltd
- Cove Dermatology Pte Ltd
- Ardennes Healthcare Pte. Ltd.
- Alo Ambulance Services Pte. Ltd.
- ALTX Limited
- VirtueMed Pte Ltd
- Naki Consolidated Pte. Ltd.
- Olive Boulevard Pte. Ltd.

Principal Commitments
- Chief Business Officer at Livingstone Health Holdings Limited
(a) Whether at any time during the last 10 years, an application or a petition under any bankruptcy law of any jurisdiction was filed against him or against a partnership of which he was a partner at the time when he was a partner or at any time within 2 years from the date he ceased to be a partner?
No
(b) Whether at any time during the last 10 years, an application or a petition under any law of any jurisdiction was filed against an entity (not being a partnership) of which he was a director or an equivalent person or a key executive, at the time when he was a director or an equivalent person or a key executive of that entity or at any time within 2 years from the date he ceased to be a director or an equivalent person or a key executive of that entity, for the winding up or dissolution of that entity or, where that entity is the trustee of a business trust, that business trust, on the ground of insolvency?
No
(c) Whether there is any unsatisfied judgment against him?
No
(d) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving fraud or dishonesty which is punishable with imprisonment, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such purpose?
No
(e) Whether he has ever been convicted of any offence, in Singapore or elsewhere, involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or has been the subject of any criminal proceedings (including any pending criminal proceedings of which he is aware) for such breach?
No
(f) Whether at any time during the last 10 years, judgment has been entered against him in any civil proceedings in Singapore or elsewhere involving a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, or a finding of fraud, misrepresentation or dishonesty on his part, or he has been the subject of any civil proceedings (including any pending civil proceedings of which he is aware) involving an allegation of fraud, misrepresentation or dishonesty on his part?
No
(g) Whether he has ever been convicted in Singapore or elsewhere of any offence in connection with the formation or management of any entity or business trust?
No
(h) Whether he has ever been disqualified from acting as a director or an equivalent person of any entity (including the trustee of a business trust), or from taking part directly or indirectly in the management of any entity or business trust?
No
(i) Whether he has ever been the subject of any order, judgment or ruling of any court, tribunal or governmental body, permanently or temporarily enjoining him from engaging in any type of business practice or activity?
No
(j) Whether he has ever, to his knowledge, been concerned with the management or conduct, in Singapore or elsewhere, of the affairs of :-
(i) any corporation which has been investigated for a breach of any law or regulatory requirement governing corporations in Singapore or elsewhere; or
No
(ii) any entity (not being a corporation) which has been investigated for a breach of any law or regulatory requirement governing such entities in Singapore or elsewhere; or
No
(iii) any business trust which has been investigated for a breach of any law or regulatory requirement governing business trusts in Singapore or elsewhere; or
No
(iv) any entity or business trust which has been investigated for a breach of any law or regulatory requirement that relates to the securities or futures industry in Singapore or elsewhere, in connection with any matter occurring or arising during that period when he was so concerned with the entity or business trust?
No
(k) Whether he has been the subject of any current or past investigation or disciplinary proceedings, or has been reprimanded or issued any warning, by the Monetary Authority of Singapore or any other regulatory authority, exchange, professional body or government agency, whether in Singapore or elsewhere?
Yes
If Yes, Please provide full details
Please refer to Appendix 1 for details (where Mr. Dax Ng was a witness to an altercation case)
Any prior experience as a director of an issuer listed on the Exchange?
No
If no, please state if the director has attended or will be attending training on the roles and responsibilities of a director of a listed issuer as prescribed by the Exchange
Completed Listed Entity Directorship (LED) courses 1-4 prior.

Mr. Dax Ng will complete the training on sustainability matters as prescribed by the SGX-ST within one year from his date of appointment.

Attachments

Appendix 1.pdf
Total size =68K